Vitality Watch

Dossier pubmed review 22-oct-2026
Narrative review or expert overview without new data

Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications.

Key claim: Age-related thyroid dysfunction drives a bidirectional feedback loop with metabolic disorders, accelerating cardiovascular-kidney-metabolic syndrome and identifying thyroid hormone receptor agonists as potential therapeutic targets.

Abstract

Thyroid hormones are involved in multiple metabolic pathways in the body and are essential for maintaining organ functions across the lifespan. Aging-related thyroid dysfunction has a bidirectional relationship with the development of chronic diseases including metabolic syndrome, diabetes, and cardiovascular disease, and contributes to the progression of cardiovascular-kidney-metabolic (CKM) syndrome via complex pathophysiological mechanisms. Systematically elaborating on the characteristics of thyroid function related to aging and its regulatory role in metabolism and cardiovascular homeostasis, can provide new therapeutic strategies and theoretical basis for revealing the molecular network and metabolic process of the CKM syndrome. In this review, we have summarized the manifestations of thyroid hormone homeostasis in age-related changes, and the underlying potential mechanisms during aging and longevity processes. Moreover, we systematically elucidated the pivotal role of thyroid hormones in cardiovascular and renal homeostasis, discussed the interplay between thyroid dysfunction and metabolic risk factors in CKM syndrome, particularly issues related to obesity, type 2 diabetes, and dyslipidemia. Patients with thyroid dysfunction develop CKM syndrome through a positive feedback loop centered on metabolic disorders and organic dysfunction. Moreover, we pointed out that novel drugs targeting thyroid hormone receptors are expected to slow down the progression of CKM syndrome and reduce cardiovascular risks.

Why this matters

Age-related thyroid dysfunction drives a bidirectional feedback loop with metabolic disorders, accelerating cardiovascular-kidney-metabolic syndrome and identifying thyroid hormone receptor agonists as potential therapeutic targets.

Source

Link

Briefing card

Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications.
Stage: review · pubmed · 22-oct-2026

Age-related thyroid dysfunction drives a bidirectional feedback loop with metabolic disorders, accelerating cardiovascular-kidney-metabolic syndrome and identifying thyroid hormone receptor agonists as potential therapeutic targets.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3389/fendo.2026.2000192

build build 880 · 2bcef25 · 2026-11-18